OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PGC57

Paragon Care Ltd

Medical Equipment, Supplies & DistributionVerified

Paragon Care Ltd's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's liquidity risk could not be assessed, and no liquidity metrics are available for comparison to industry medians. Profitability and returns data are not available for Paragon Care Ltd, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or ROIC figures, it is not possible to assess the company's performance relative to its peers. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains unknown. Growth trajectory data is not available for Paragon Care Ltd. No revenue history or outlook numeric deltas are provided, preventing an assessment of the company's growth potential or direction. Risk factors include an inability to assess liquidity risk due to missing balance-sheet data. Dilution risk is currently low, and no adjustments have been applied to valuation metrics. However, the absence of financial data limits the ability to evaluate other risk factors comprehensively. Recent events and filings are not disclosed in the available source documents. No transcripts or material events are available to inform the company's current strategic or operational direction.

30-day price · PGC-0.03 (-14.7%)
Low$0.14High$0.18Close$0.14As of26 May, 00:00 UTC
Profile
CompanyParagon Care Ltd
TickerPGC.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Paragon Care Ltd operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.

Classification. Paragon Care Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Paragon Care Ltd's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's liquidity risk could not be assessed, and no liquidity metrics are available for comparison to industry medians. Profitability and returns data are not available for Paragon Care Ltd, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or ROIC figures, it is not possible to assess the company's performance relative to its peers. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to evaluate revenue concentration or geographic diversification. The company's exposure to specific markets or product lines remains unknown. Growth trajectory data is not available for Paragon Care Ltd. No revenue history or outlook numeric deltas are provided, preventing an assessment of the company's growth potential or direction. Risk factors include an inability to assess liquidity risk due to missing balance-sheet data. Dilution risk is currently low, and no adjustments have been applied to valuation metrics. However, the absence of financial data limits the ability to evaluate other risk factors comprehensively. Recent events and filings are not disclosed in the available source documents. No transcripts or material events are available to inform the company's current strategic or operational direction.
Key takeaways
  • Paragon Care Ltd's liquidity and capital structure cannot be assessed due to missing balance-sheet data.
  • Profitability and returns metrics are not available, preventing a comparison to industry benchmarks.
  • No segment or geographic exposure data is disclosed, limiting visibility into revenue concentration.
  • Growth trajectory and outlook data are not available, making it difficult to assess future performance.
  • Dilution risk is currently low, but the absence of financial data limits the ability to evaluate other risk factors.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$235.9M$20.3M$8.3M$9.2M
FY-3$237.8M$16.0M$6.4M$9.9M
FY-2$2.19B$29.1M$12.6M$10.6M
FY-1$2.97B$29.8M$8.2M-$9.0M
FY0$3.62B$58.6M$20.6M$33.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$291.9M$121.5M
FY-3$438.4M$235.8M
FY-2$492.4M$18.9M
FY-1$1.15B$291.7M
FY0$1.24B$329.8M
PeriodOCFCapExFCFSBC
FY-4$27.5M-$5.3M$9.2M
FY-3$19.0M-$4.6M$9.9M
FY-2$22.4M-$9.7M$10.6M
FY-1$44.5M-$19.3M-$9.0M
FY0-$13.4M-$16.9M$33.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricPGCActivity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Observations
IR observations
Mean price target0.33 AUD
Median price target0.33 AUD
High price target0.35 AUD
Low price target0.30 AUD
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.02 AUD
Last actual EPS0.02 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-23 00:32 UTC#024d44c8
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 23:17 UTCJob: 0463a47f